re
di
ct
ed
d
at
a
93
87
81
75
69
Figure 4a.
Regression of calibration samples (Primary method vs NIR data).
69 74 79 84 89 9994 104 109 114 119 124 129 134
1.46364.0006 Page 3 of 4
Quality Control
Function Control strains mediumIncubation Reference
Method of
control
Expected
results
Productivity
Lactobacillus sakei
ATCC® 15521
69-75 h at
References
1. Oyler, G.A. et al., J. Cell. Biol., 109, 3039 (1989).
2. Oyler, G.A., et al., Proc. Natl. Acad. Sci. USA, 88,
5247 (1991).
3. Söllner, T. et al., Nature, 362, 318 (1993).
References
1. Oyler, G. A., et al., J. Cell. Biol., 109, 3039 (1989).
2. Oyler, G. A., et al., Proc. Natl. Acad. Sci. USA, 88,
5247 (1991).
3. Söllner, T., et al., Nature, 362, 318 (1993).
4.
glycerol.
Molecular mass: ∼74 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 81–109 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
glycerol.
Molecular mass: ∼74 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 81–109 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
3rd ed. (Rose, N.R.
et al., eds.). American Society for Microbiology
(Washington, D.C.), pp. 99-109 (1986).
4. Mlinar, Diana, "The Role of Trappin-2 and RANTES
in Mediating Resistance to HIV-1 Infection
freezer.
References
1. MacArthur, C.A., et al., J. Virol., 69, 2501 (1995).
2. Givol, D., and Yayon, A., FASEB. J., 6, 3362
(1992).
3. Baird, A., et al., Curr. Opin. Neurobiol., 4, 78
(1994).
glycerol.
Molecular mass: ∼74 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 81–109 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Neurosci., 3, 437-444 (2000).
76. Fujikawa, A., et al., Nat. Genet., 33, 375-381 (2003).
77. Yahiro, K., et al., J. Biol. Chem., 278, 19183-19189 (2003).
78. Liu, K., et al., J. Virol., 69, 7823-7834 (
study
of LOV–LOV interactions”. Universität
Regensburg, Dr. rer. nat. dissertation, pp. 107,
109 (2017).
13. Eichner, Ruth, “Functional characterization of
Cereblon, the molecular target of
scale) (3)
Day 0 Day 5 Days 8−10 Days 11−15 Days 14−20
Cell detachment Media exchange,
cell detachment
Media exchange,
cell detachment
Media exchange~150 × 106 cells
~300−350
× 109 cells